1. Pink Sheet
  2. >>Market Access
  3. >>Pricing Debate

HHS Rulemaking On Price Disclosures In DTC Ads Supported In Senate-Passed Bill

 
• By Cathy Kelly

US congressional action comes as HHS forwards proposed rule on enhancing drug pricing transparency to Office of Management and Budget for review.

As seen on tv with retro television icon

The US Senate approved a federal spending billl Aug. 23 that includes a provision authorizing HHS to develop regulations requiring the disclosure of prescription drug pricing in direct-to-consumer advertising and providing funding for it.

H.R

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Pricing Debate

More from Market Access